Detailed information for compound 410203

Basic information

Technical information
  • TDR Targets ID: 410203
  • Name: 4-chloro-3-methoxy-N-[[4-(1-oxidopyridin-1-iu m-2-yl)piperidin-1-yl]methyl]benzamide
  • MW: 375.849 | Formula: C19H22ClN3O3
  • H donors: 1 H acceptors: 2 LogP: 2.14 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(ccc1Cl)C(=O)NCN1CCC(CC1)c1cccc[n+]1[O-]
  • InChi: 1S/C19H22ClN3O3/c1-26-18-12-15(5-6-16(18)20)19(24)21-13-22-10-7-14(8-11-22)17-4-2-3-9-23(17)25/h2-6,9,12,14H,7-8,10-11,13H2,1H3,(H,21,24)
  • InChiKey: BRFQMZIDDPTDFT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-chloro-3-methoxy-N-[[4-(1-oxidopyridin-1-ium-2-yl)-1-piperidyl]methyl]benzamide
  • 4-chloro-3-methoxy-N-[[4-(1-oxido-2-pyridin-1-iumyl)-1-piperidinyl]methyl]benzamide
  • 4-chloro-3-methoxy-N-[[4-(1-oxidanidylpyridin-1-ium-2-yl)piperidin-1-yl]methyl]benzamide
  • 4-chloro-3-methoxy-N-[[4-(1-oxidopyridin-1-ium-2-yl)piperidino]methyl]benzamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens dopamine receptor D4 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Giardia lamblia Rrm3p helicase 0.1066 0.8728 1
Trypanosoma brucei mitochondrial DNA polymerase beta-PAK 0.0572 0.4281 0.4281
Trypanosoma cruzi DNA repair and recombination helicase protein PIF6, putative 0.1066 0.8728 0.8728
Trypanosoma brucei mitochondrial DNA polymerase beta 0.1208 1 1
Loa Loa (eye worm) hypothetical protein 0.0301 0.1843 0.5
Trypanosoma brucei DNA repair and recombination helicase protein PIF6 0.1066 0.8728 0.8728
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.1066 0.8728 0.8728
Brugia malayi DNA polymerase alpha catalytic subunit 0.0177 0.0736 0.5
Toxoplasma gondii hypothetical protein 0.0195 0.0893 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0207 0.1003 0.1003
Mycobacterium ulcerans hypothetical protein 0.0636 0.4861 0.5
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.1208 1 1
Leishmania major PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative 0.1066 0.8728 0.8728
Trichomonas vaginalis conserved hypothetical protein 0.1066 0.8728 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.017 0.0669 0.0669
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.1066 0.8728 0.8728
Plasmodium vivax DNA polymerase alpha, putative 0.0177 0.0736 0.5
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0572 0.4281 0.4281
Onchocerca volvulus DNA polymerase alpha catalytic subunit homolog 0.0301 0.1843 0.5
Leishmania major PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative 0.1066 0.8728 0.8728
Trypanosoma brucei DNA polymerase beta thumb, putative 0.017 0.0669 0.0669
Trypanosoma cruzi DNA polymerase beta thumb, putative 0.017 0.0669 0.0669
Entamoeba histolytica hypothetical protein, conserved 0.1066 0.8728 0.5
Trypanosoma brucei DNA repair and recombination helicase protein PIF7 0.1066 0.8728 0.8728
Echinococcus granulosus ATP dependent DNA helicase PIF1 0.1066 0.8728 1
Schistosoma mansoni hypothetical protein 0.1066 0.8728 1
Trypanosoma cruzi DNA polymerase beta thumb, putative 0.017 0.0669 0.0669
Entamoeba histolytica DNA repair and recombination protein, putative 0.1066 0.8728 0.5
Echinococcus multilocularis ATP dependent DNA helicase PIF1 0.1066 0.8728 1
Leishmania major mitochondrial DNA polymerase beta-PAK, putative 0.0572 0.4281 0.4281
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.1208 1 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0636 0.4861 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 159 nM Agonist activity at human D4.4 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR ChEMBL. 17149874
EC50 (functional) = 159 nM Agonist activity at human D4.4 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR ChEMBL. 17149874
Efficacy (functional) = 54 % Agonist activity at human D4.4 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR with relative to dopamine ChEMBL. 17149874
Efficacy (functional) = 54 % Agonist activity at human D4.4 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR with relative to dopamine ChEMBL. 17149874

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.